pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 29 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05934838: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06788938: Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE2. Conditions: DLL3-expressing Tumors, Advanced Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06842238: Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation

    Sponsor: Elsan. Phase: . Conditions: Bronchiolitis, Bronchiolitis Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01274338: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06983158: A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

    Sponsor: Capsida Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Developmental and Epileptic Encephalopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07308158: Covid Flu A/B and RSV 4 in 1 Diagnostic Test

    Sponsor: iHealth Labs inc. Phase: . Conditions: Influenza A, Influenza B, COVID - 19, RSV

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06697158: Investigation of the Effects of Complex Decongestive Physiotherapy on Sleep Quality and Quality of Life in Women With Breast Cancer Related Lymphedema

    Sponsor: Abant Izzet Baysal University. Phase: NA. Conditions: Breast Cancer Related Lymphedema

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07591948: The Effect of Low-Level Laser Therapy on Accelerating Tooth Movement and Reducing Pain During Orthodontic Treatment

    Sponsor: Sana'a University. Phase: NA. Conditions: Acceleration of Tooth Movement

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05003648: Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

    Sponsor: Massachusetts General Hospital. Phase: PHASE4. Conditions: Adrenoleukodystrophy, Restless Legs Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07664748: Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

    Sponsor: Niguarda Hospital. Phase: NA. Conditions: Heart Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06669455: An Integrated and Personalized Lifestyle Approach for People With Parkinson's Disease

    Sponsor: Radboud University Medical Center. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04221555: Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma

    Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06867055: Evaluation of the Effectiveness of Different Procedures on Palatinal Wound Healing After Free Gingival Graft Surgery.

    Sponsor: SEVAL CEYLAN ŞEN. Phase: NA. Conditions: Insufficient Keratinized Gingiva

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07397026: Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial

    Sponsor: Hagar Ahmed Ali Mohammed Elzain. Phase: PHASE1. Conditions: Periodontitis Stage III

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07478926: Flow Detection in Open and Closed Shunt Valve Periods

    Sponsor: Rhaeos, Inc.. Phase: NA. Conditions: Hydrocephalus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06044285: Ultra Crave: An Investigation of Ultra-Processed Food

    Sponsor: University of Michigan. Phase: NA. Conditions: Food Addiction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06809543: Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy

    Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Rotator Cuff Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06788743: Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial

    Sponsor: Xijing Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Diabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07582770: Cognitive Impairment Assessment in Breast Cancer Survivors

    Sponsor: European Institute of Oncology. Phase: . Conditions: Cancer Related Cognitive Impairment, Breast Cancer Survivors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07381569: To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion

    Sponsor: Peking Union Medical College Hospital. Phase: NA. Conditions: Abortion, Induced

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07364669: Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects

    Sponsor: Laboratorios Pisa S.A. de C.V.. Phase: PHASE1. Conditions: Healthy Subjects

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04189783: Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Retroperitoneal Sarcoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06408441: The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

    Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. Phase: . Conditions: Epithelioid Hemangioendothelioma, Sarcoma,Soft Tissue

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05446194: Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease

    Sponsor: University of Michigan. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06656494: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

    Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.. Phase: PHASE1. Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07622394: Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors

    Sponsor: Xinjiang Medical University. Phase: NA. Conditions: Cancer Therapy-Related Cardiac Dysfunction, Cardio-oncology, Cancer Survivorship, Cardiovascular Risk, Heart Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03674229: Patients Navigators in Facilitating Weight Management in Obese Participants

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Health Status Unknown, Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06055231: PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Cigarette Smoking-Related Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07480031: Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilation During Facemask Ventilation in Morbidly Obese Patients

    Sponsor: Benha University. Phase: NA. Conditions: Gastric Insufflation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05819931: Breathing With Amyotrophic Lateral Sclerosis

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06954402: Resilience Among Individuals With Opioid Use Disorder

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04627753: Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

    Sponsor: Kim, Seok Jin. Phase: PHASE2. Conditions: Primary CNS Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07597902: SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Post-acute Sequelae of COVID-19, Long COVID

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07517653: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

    Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE2. Conditions: Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05504837: A Study Assessing KB407 for the Treatment of Cystic Fibrosis

    Sponsor: Krystal Biotech, Inc.. Phase: PHASE1. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00953537: Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

    Sponsor: Centre Antoine Lacassagne. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557537: A Phase 1 Study of KHN707 Tablets in Healthy Participants

    Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Participants

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07622095: Validation of the French Version of the New Mobility Score (NMS)

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Hip Fractures, Mobility Limitation, Independence, Autonomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07182877: Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous Cannula

    Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh. Phase: NA. Conditions: Thrombophlebitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07063277: Comparison of Oxygen Reserve Index and Spirometry in Predicting Respiratory Complications After Coronary Artery Bypass Surgery

    Sponsor: Ankara Bilkent Sehir Hastanesi. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Coronary Artery Bypass Graft (CABG), Postoperative Pulmonary Complication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316777: Saudi CABG Audit and Registry

    Sponsor: King Faisal Specialist Hospital & Research Center. Phase: . Conditions: Coronary Artery Bypass Graft (CABG)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07407257: SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Liver Neoplasms, Liver Metastases, Pancreatic Neoplasms

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07642401: Large-scale Models of Esophageal Cancer and Related Research

    Sponsor: The First Affiliated Hospital of Henan University of Science and Technology. Phase: . Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT07173101: Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients

    Sponsor: University of Utah. Phase: PHASE2. Conditions: Breast Cancer, Gynecologic Cancer, Cancer-related Cognitive Difficulties

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06787612: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06568601: Pharmacogenomic Informed Statin Prescribing

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06217601: Impact Evaluation of the Digital Connect Project for Homebound Older Adults

    Sponsor: The University of Hong Kong. Phase: NA. Conditions: Aging Well

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant

    Sponsor: University of Manitoba. Phase: PHASE2. Conditions: Kidney Transplant; Complications, Rejection of Renal Transplant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07147101: Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

    Sponsor: Fudan University. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05513001: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Chronic Spontaneous Urticaria

    full page →ctgov ↗
    ← prev
    page 73 of 104
    next →